Skip to content
MMM909090

Drawing based on the label description. No photo yet.

“Ticagrelor tablets, 90 mg is supplied as a round, biconvex, yellow, film-coated tablets debossed with "M" on one side and "90" on other side”

M 90 pill

Pill with imprint M 90 is yellow, round, 9 mm and has been identified as Ticagrelor 90 mg. It is supplied by Novadoz Pharmaceuticals LLC.

Ticagrelor 90 mg

Imprint
M 90
Strength
90 mg
Color
Yellow
Shape
Round
Size
9 mm
Score
No score line
Form
Tablet
Manufacturer
Novadoz Pharmaceuticals LLC
Drug class
Antiplatelet medicine (prevents clots)
NDC
72205-368, 72205-368-60, 72205-368-91, 72205-368-18, 72205-368-99, 72205-368-11, 73190-008, 73190-008-60, 50268-826, 50268-826-11, 50268-826-01, 53401-028, 53401-028-42, 60687-928, 60687-928-11, 60687-928-57

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Ticagrelor pills and guides

What is Ticagrelor used for?

Ticagrelor is an antiplatelet medicine (prevents clots).

Medicine type
Antiplatelet medicine (prevents clots)
Official uses from the US prescribing label

Acute Coronary Syndrome or a History of Myocardial Infarction

Ticagrelor tablets are indicated to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel.

Ticagrelor tablet also reduces the risk of stent thrombosis in patients who have been stented for treatment of ACS.

Coronary Artery Disease but No Prior Stroke or Myocardial Infarction

Ticagrelor tablet is indicated to reduce the risk of a first MI or stroke in patients with coronary artery disease (CAD) at high risk for such events. While use is not limited to this setting, the efficacy of ticagrelor tablet was established in a population with type 2 diabetes mellitus (T2DM).

Acute Ischemic Stroke or Transient Ischemic Attack (TIA)

Ticagrelor tablet is indicated to reduce the risk of stroke in patients with acute ischemic stroke (NIH Stroke Scale score ≤5) or high-risk transient ischemic attack (TIA).

From the FDA-approved label on DailyMed (published Sep 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows M and the other side shows 90.
  • It is yellow, round, 9 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Ticagrelor

Inactive: Croscarmellose Sodium, Talc, Titanium Dioxide, Anhydrous Dibasic Calcium Phosphate, Hydroxypropyl Cellulose, Unspecified, Magnesium Stearate, Mannitol, Hypromellose, Unspecified, Ferric Oxide Red, Ferric Oxide Yellow, Polyethylene Glycol 400

Also distributed by

Avkare, Avpak, Aphena Pharma Solutions - Tennessee, LLC, American Health Packaging

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Ticagrelor pills